Gene Splicing Reduces Effectiveness of CD20-Targeting Monoclonal Antibodies Designed to Treat Variety of Blood Cancers and Disorders

–Researchers found CAR T-cell therapy may serve as effective alternative for patients with these disorders — PHILADELPHIA, Nov. 17, 2023 /PRNewswire/ — Immunotherapies that target the CD20 antigen have revolutionized how patients with a variety of blood cancers and hematologic…